To further elucidate telomere stabilization in MTC we characterized a panel of tumors for activation of telomerase or the ALT mechanism in relation to RET mutational status, clinical characteristics, and patient outcomes. This evidence concerns the gene RET and medullary thyroid gland carcinoma.